Gujarat Themis Biosyn Files Audited FY26 Financial Statements

Gujarat Themis Biosyn Ltd has submitted its audited financial statements for the quarter and year ended March 31, 2026, as per Regulation 30 (LODR). These statements, along with the auditor's report, were previously considered and approved by the Board of Directors on May 25, 2026. The financial statements provide a true and fair view of the company's affairs in conformity with Indian Accounting Standards. Key audit matters highlighted include revenue recognition and capital work-in-progress/Property Plant and Equipment. The statements are subject to adoption by shareholders at the upcoming Annual General Meeting and are available on the company's website.